Patentability of Human Enhancement: From Ethical Dilemmas to Legal (Un)Certainty

A. Nordberg
{"title":"Patentability of Human Enhancement: From Ethical Dilemmas to Legal (Un)Certainty","authors":"A. Nordberg","doi":"10.4337/9781786436382.00009","DOIUrl":null,"url":null,"abstract":"Emerging technologies, such as nanotechnology, are paving the way for future revolutionary advances in science that may open the possibility to change the very anthropological definition of human being. This mere possibility has lead to ethical interrogations concerning the nature and boundaries of human nature and our relationship with science and technology. Meanwhile the Law has faced the challenge of reflecting on the legitimacy to legislate and whether the existing legal framework is appropriate to address the ethical concerns that emerging technologies bring fourth. It is a delicate balancing act between human dignity, autonomy, non-discrimination, equality, and justice. Anchored in this background, this work is a reflection on the role of European Patent Law in this debate. The European Patent system contains rules designed to prevent the grant of patents concerning inventions that do not conform to the prevailing ethical standards – article 53 (a) European Patent Convention. Thus, in a sense European Patent Law was entrusted with a regulatory function. However, not only such construction is objectionable in abstract terms, as new technologies pose growing challenges to its effectiveness. Several issues require clarification. First, while the EPO Boards of appeal may have institutional legitimacy to determine if a certain technology or technological field conforms with the prevailing ethical principles in Europe, it is more difficult to accept that the European Patent Office Boards of Appeal may have been given the task to autonomously determine what is to be considered the common prevailing ethical standards of the signatory states to the European Patent Convention. Second, new technologies typically have a mixed nature, offering a wide range of uncontroversial benefits to humanity while simultaneously posing complex ethical challenges. Third, the patent system by its nature can only go as far as reducing economic incentive to innovation leading to non-ethical inventions. Thus, the debates concerning the patentability of human enhancement need to be closely linked to the function of patents and the ratio legis of the specific patent norm.This article will begin by analyzing the concept of human enhancement and proposing for the current patent law analysis purposes its replacement with a more neutral term and narrow definition. The ethical questions surrounding these technological advances and prospects will be reviewed from a legal perspective, by framing such ethical considerations as human rights and general principles of law. Building upon the previous considerations the third part of this article will consider the patentability of technologies that provide the means to intentionally develop, modify or introduce in the human body aesthetic features, physical or cognitive performance levels and abilities beyond the human species typical standards under the current evolutionary state, and resulting in induced permanent alterations in light of the current rules of the European Patent Convention, corresponding implementing regulation rules (correspondents to the Biotechnology Directive) and EPO Boards of Appeal decisions.","PeriodicalId":289083,"journal":{"name":"PRN: Business & Professional Ethics (Sub-Topic)","volume":"37 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2014-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PRN: Business & Professional Ethics (Sub-Topic)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4337/9781786436382.00009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Emerging technologies, such as nanotechnology, are paving the way for future revolutionary advances in science that may open the possibility to change the very anthropological definition of human being. This mere possibility has lead to ethical interrogations concerning the nature and boundaries of human nature and our relationship with science and technology. Meanwhile the Law has faced the challenge of reflecting on the legitimacy to legislate and whether the existing legal framework is appropriate to address the ethical concerns that emerging technologies bring fourth. It is a delicate balancing act between human dignity, autonomy, non-discrimination, equality, and justice. Anchored in this background, this work is a reflection on the role of European Patent Law in this debate. The European Patent system contains rules designed to prevent the grant of patents concerning inventions that do not conform to the prevailing ethical standards – article 53 (a) European Patent Convention. Thus, in a sense European Patent Law was entrusted with a regulatory function. However, not only such construction is objectionable in abstract terms, as new technologies pose growing challenges to its effectiveness. Several issues require clarification. First, while the EPO Boards of appeal may have institutional legitimacy to determine if a certain technology or technological field conforms with the prevailing ethical principles in Europe, it is more difficult to accept that the European Patent Office Boards of Appeal may have been given the task to autonomously determine what is to be considered the common prevailing ethical standards of the signatory states to the European Patent Convention. Second, new technologies typically have a mixed nature, offering a wide range of uncontroversial benefits to humanity while simultaneously posing complex ethical challenges. Third, the patent system by its nature can only go as far as reducing economic incentive to innovation leading to non-ethical inventions. Thus, the debates concerning the patentability of human enhancement need to be closely linked to the function of patents and the ratio legis of the specific patent norm.This article will begin by analyzing the concept of human enhancement and proposing for the current patent law analysis purposes its replacement with a more neutral term and narrow definition. The ethical questions surrounding these technological advances and prospects will be reviewed from a legal perspective, by framing such ethical considerations as human rights and general principles of law. Building upon the previous considerations the third part of this article will consider the patentability of technologies that provide the means to intentionally develop, modify or introduce in the human body aesthetic features, physical or cognitive performance levels and abilities beyond the human species typical standards under the current evolutionary state, and resulting in induced permanent alterations in light of the current rules of the European Patent Convention, corresponding implementing regulation rules (correspondents to the Biotechnology Directive) and EPO Boards of Appeal decisions.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人类进步的可专利性:从伦理困境到法律(不)确定性
新兴技术,如纳米技术,正在为未来科学的革命性进步铺平道路,这可能开启改变人类的人类学定义的可能性。这种纯粹的可能性导致了对人性的本质和界限以及我们与科学技术的关系的伦理质疑。与此同时,法律面临的挑战是反思立法的合法性,以及现有的法律框架是否适合解决新兴技术带来的道德问题。这是人的尊严、自主、不歧视、平等和正义之间的微妙平衡。在这种背景下,这项工作是对欧洲专利法在这场辩论中的作用的反思。欧洲专利制度包含旨在防止授予不符合现行道德标准的发明专利的规则- -《欧洲专利公约》第53 (a)条。因此,在某种意义上,欧洲专利法被赋予了监管职能。然而,这种结构不仅在抽象意义上是令人反感的,因为新技术对其有效性提出了越来越多的挑战。有几个问题需要澄清。首先,虽然欧洲专利局上诉委员会在确定某项技术或技术领域是否符合欧洲普遍的道德原则方面可能具有制度上的合法性,但欧洲专利局上诉委员会可能被赋予了自主确定《欧洲专利公约》签署国共同普遍的道德标准的任务,这一点更难以接受。其次,新技术通常具有混合性质,在为人类提供广泛的无可争议的好处的同时,也提出了复杂的伦理挑战。第三,专利制度就其本质而言,只能减少对创新的经济激励,从而导致不道德的发明。因此,关于人类增强的可专利性的争论需要与专利的功能和特定专利规范的比例法律紧密联系起来。本文将首先分析人类增强的概念,并为当前专利法分析的目的提出用一个更中性的术语和更狭义的定义来代替它。围绕这些技术进步和前景的伦理问题将从法律角度加以审查,方法是将诸如人权和一般法律原则等伦理方面的考虑加以框定。在前面考虑的基础上,本文的第三部分将考虑技术的可专利性,这些技术提供了在当前进化状态下有意开发、修改或引入人体美学特征、身体或认知表现水平和能力的手段,超出了人类物种的典型标准,并根据欧洲专利公约的现行规则导致诱发的永久性改变。相应的实施条例规则(对应于生物技术指令)和欧洲专利局上诉委员会的决定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Trust Platforms: The Digitalization of Corporate Governance and the Transformation of Trust in Polycentric Space Some Questions of Ethics in RCTs Reforzar la integridad empresarial ante la crisis del Covid-19 (Strengthening Business Integrity in the Face of the COVID-19 Crisis) Islamic and Conventional Economics – Dialogue and Ethics Novel Personal Corporate Structures, Fiduciary Responsibility, and the Ethics of Personhood
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1